Cart
sales@molnova.com
Ralmitaront
CAS No. 2133417-13-5
Ralmitaront( RO6889450 )
Catalog No. M23969 CAS No. 2133417-13-5
Ralmitaront is a potent, orally active partial agonist of the trace amine-associated receptor 1 (TAAR1).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 302 | In Stock |
|
| 5MG | 275 | In Stock |
|
| 10MG | 424 | In Stock |
|
| 25MG | 706 | In Stock |
|
| 50MG | 926 | In Stock |
|
| 100MG | 1283 | In Stock |
|
| 200MG | 1748 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRalmitaront
-
NoteResearch use only, not for human use.
-
Brief DescriptionRalmitaront is a potent, orally active partial agonist of the trace amine-associated receptor 1 (TAAR1).
-
DescriptionRalmitaront is a potent, orally active partial agonist of the trace amine-associated receptor 1 (TAAR1).
-
In Vitro——
-
In Vivo——
-
SynonymsRO6889450
-
PathwayOthers
-
TargetOther Targets
-
Recptoramine-associated receptor 1 (TAAR1)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2133417-13-5
-
Formula Weight314.38
-
Molecular FormulaC17H22N4O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:90mg/ml(286.28mM; Need ultrasonic)
-
SMILESCCc1c(C)c(C(Nc2ccc([C@@H]3OCCNC3)cc2)=O)n[nH]1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Brady LS, Potter WZ, Gordon JA. Redirecting the revolution: new developments in drug development for psychiatry. Expert Opin Drug Discovery. 2019;14:1213–1219.
molnova catalog
related products
-
ZD-6888 Hydrochlorid...
ZD-6888 Hydrochloride, an angiotensin type 1 receptor antagonist, is used potentially for the treatment of hypertension.
-
AVE5688
AVE5688, an inhibitor of glycogen phosphorylase (GP), has IC50 values of 430 nM and 915 nM, and Kd values of 170 nM and 530 nM for rmGPb and rmGPa, respectively.
-
Phenibut (hydrochlor...
Phenibut (hydrochloride)?is a GABA mimetic that acts as an agonist at GABAB receptors, blocks α2δ subunit-containing voltage-gated calcium channels, stimulates dopamine receptors, and inhibits the actions of β-phenethylamine.
